Study of Gemcitabine With TheraSphere® (Yttrium-90)in Patients With Hepatic Tumors of Pancreatobiliary Origin

NCT01434459 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

9

Enrollment

OTHER

Sponsor class

Stopped PI moved to different institution

Conditions

Pancreatic Neoplasms
Cholangiocarcinoma

Interventions

DRUG: Gemcitabine with TheraSphere

Sponsor

Emory University